Pfizer and partner BioNTech are seeking the FDA’s emergency approval to administer third doses of its vaccine to people 16 and over across the U.S. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.